Welcome to Iris Biotech
For better service please confirm your country and language we detected.
Currency
EUR
Contact rapide
Veuillez m'envoyer plus d'informations sur
Fmoc-L-Lys(Ggu-L-Glu(AA-AA))-OH
Nom chimique: Fmoc-Lys(tBu-OOC-C16-CO-Glu(AEEA-AEEA)-OtBu)-OH // Synonymes: (23S,50S)-50-(((9H-fluoren-9-yl)methoxy)carbonylamino)-23-(tert-butoxycarbonyl)-2,2-dimethyl-4,21,26,35,44-pentaoxo-3,30,33,39,42-pentaoxa-22,27,36,45-tetraazahenpentacontan-51-oicacid, Semaglutide- Linker, Fmoc-Lys(Ggu-L-Glu(AA-AA)-OH
- n° Art.:FAA7640
- n° CAS:1662688-20-1
- Formule:C64H101N5O16
- Storage temperature:-20°C
- Masse moléculaire:1196,51 g/mol
from 390,00 €
description
Dipeptide building block for SPPS synthesis of Semaglutide (brand name Ozempic). Semaglutide is a GLP-1 analogue and has been developed in 2012 by Novo Nordisk SA for the treatment of diabetes type 2 as a longer-acting alternative to liraglutide. It was found in 2017 that it also can be used for the treatment of obesity.
references
"Abstracts of the 48th EASD Annual Meeting of the European Association for the Study of Diabetes". Diabetologia 2012; 55(1): 1–538. DOI: 10.1007/s00125-012-2688-9.
* Disclaimer
We refer to our general terms and conditions.
All information contained in our webshop is compiled to the best of our knowledge.
Prices and product availability are subject to change and require reconfirmation. Please contact us for further information.
All information contained in our webshop is compiled to the best of our knowledge.
Prices and product availability are subject to change and require reconfirmation. Please contact us for further information.
Besoin d'informations supplémentaires sur ce produit?
entrer en contact
Brochures et dépliants
Des produits qui pourraient également vous intéresser!
